Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
CALL
United Rentals
URI
$65.7B
| $17.5M | 0.01% |
50,000
+49,000
| +4,900% | +$16.4M |
|
|
FVIV
1427
DELISTED
Fortress Value Acquisition Corp. IV
FVIV
| $17.5M | 0.01% |
1,799,415
-1,178,061
| -40% | -$11.5M |
|
1428
Ginkgo Bioworks
DNA
$498M
| $17.5M | 0.01% |
+37,786
| New | +$18.4M |
|
|
ALIT.WS
1429
CALL
DELISTED
Alight Inc Warrants
ALIT.WS
| $17.5M | 0.01% |
+5,741,344
| New | +$14.3M |
|
1430
Ciena
CIEN
$46.8B
| $17.5M | 0.01% |
340,871
+283,222
| +491% | +$15.7M |
|
1431
Arch Capital
ACGL
$35.7B
| $17.5M | 0.01% |
458,287
+92,419
| +25% | +$3.66M |
|
1432
Definitive Healthcare
DH
$77M
| $17.5M | 0.01% |
+408,076
| New | +$18.1M |
|
|
SCHW
1433
CALL
Charles Schwab
SCHW
$182B
| $17.4M | 0.01% |
239,500
+26,700
| +13% | +$1.91M |
|
1434
Williams Companies
WMB
$85.8B
| $17.4M | 0.01% |
671,175
-2,312,106
| -78% | -$58.2M |
|
1435
i3 Verticals
IIIV
$419M
| $17.4M | 0.01% |
717,417
+31,338
| +5% | +$904K |
|
|
ENPC
1436
DELISTED
Executive Network Partnering Corporation
ENPC
| $17.4M | 0.01% |
1,767,004
-986,208
| -36% | -$9.6M |
|
|
DISH
1437
DELISTED
DISH Network Corp.
DISH
| $17.3M | 0.01% |
398,351
+378,904
| +1,948% | +$16.1M |
|
1438
Appian
APPN
$2.11B
| $17.3M | 0.01% |
186,745
+111,476
| +148% | +$12.3M |
|
1439
CALL
Expedia Group
EXPE
$36.5B
| $17.2M | 0.01% |
105,000
+90,000
| +600% | +$13.9M |
|
|
EOCW.U
1440
DELISTED
Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
EOCW.U
| $17.2M | 0.01% |
1,696,500
| – | – |
|
1441
Workiva
WK
$3.45B
| $17.1M | 0.01% |
121,661
-14,675
| -11% | -$1.99M |
|
1442
PUT
Altria Group
MO
$125B
| $17.1M | 0.01% |
376,700
+337,100
| +851% | +$16.3M |
|
|
STRE
1443
DELISTED
Supernova Partners Acquisition Company III, Ltd.
STRE
| $17.1M | 0.01% |
1,764,242
+342,627
| +24% | +$3.34M |
|
1444
Four Corners Property Trust
FCPT
$2.89B
| $17.1M | 0.01% |
636,528
+289,585
| +83% | +$8.11M |
|
1445
iShares Global Clean Energy ETF
ICLN
$2.22B
| $17.1M | 0.01% |
789,018
+286,194
| +57% | +$6.52M |
|
1446
LendingTree
TREE
$551M
| $17.1M | 0.01% |
122,131
+58,335
| +91% | +$10.2M |
|
1447
Western Union
WU
$2.53B
| $17M | 0.01% |
841,329
+88,759
| +12% | +$1.96M |
|
1448
Tronox
TROX
$967M
| $17M | 0.01% |
690,117
-341,122
| -33% | -$7.01M |
|
|
AVID
1449
DELISTED
Avid Technology Inc
AVID
| $17M | 0.01% |
587,636
-183,341
| -24% | -$5.66M |
|
1450
AbCellera Biologics
ABCL
$1.65B
| $17M | 0.01% |
847,819
+782,162
| +1,191% | +$13.8M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.